EUVIMEDEUVIMED entdecken
Crossref

An Intranasal Multivalent Epitope-Based Nanoparticle Vaccine Confers Broad Protection against Divergent Influenza Viruses

Jingdi Pan, Qihui Wang, Mi Qi, Jianjun Chen, Xuefan Wu, Xiaowei Zhang, Wei Li, Xian-En Zhang iD, Zongqiang Cui iD

ACS Nano · 25.07.2023 · 17 (14) · 13474-13487

DOI: 10.1021/acsnano.3c01829 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 03.07.2023. Verfasst von Jingdi Pan und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, People's…. Hauptthemen laut MEDLINE: Influenza, Human, Influenza Vaccines, Orthomyxoviridae Infections, Orthomyxoviridae. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanInfluenza VaccinesOrthomyxoviridae InfectionsOrthomyxoviridaeNanoparticlesAnimalsMiceHumansEpitopesAntibodies, ViralHemagglutinin Glycoproteins, Influenza VirusMice, Inbred BALB C

Stichwörter der Autor:innen

FerritinInfluenza virusMultivalent epitopesNanoparticle vaccineUniversal influenza vaccine

Substanzen

Influenza VaccinesEpitopesAntibodies, ViralHemagglutinin Glycoproteins, Influenza Virus

Autor:innen und Institutionen

  • State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, People's Republic of China.
  • University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China.
  • Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.

ORCID-Profile: Xian-En Zhang, Zongqiang Cui

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Chinese Academy of Sciences

Zitieren

APA

Pan, J., Wang, Q., Qi, M., Chen, J., Wu, X., Zhang, X., Li, W., Zhang, X. E., & Cui, Z. (2023). An Intranasal Multivalent Epitope-Based Nanoparticle Vaccine Confers Broad Protection against Divergent Influenza Viruses. ACS Nano, 17(14), 13474-13487. https://doi.org/10.1021/acsnano.3c01829

Vancouver

Pan J, Wang Q, Qi M, Chen J, Wu X, Zhang X, et al. An Intranasal Multivalent Epitope-Based Nanoparticle Vaccine Confers Broad Protection against Divergent Influenza Viruses. ACS Nano. 2023;17(14):13474-13487. doi:10.1021/acsnano.3c01829

BibTeX
@article{Pan2023,
  author = {Pan, Jingdi and Wang, Qihui and Qi, Mi and Chen, Jianjun and Wu, Xuefan and Zhang, Xiaowei and Li, Wei and Zhang, Xian-En and Cui, Zongqiang},
  title = {An Intranasal Multivalent Epitope-Based Nanoparticle Vaccine Confers Broad Protection against Divergent Influenza Viruses},
  journal = {ACS Nano},
  year = {2023},
  volume = {17},
  number = {14},
  pages = {13474--13487},
  doi = {10.1021/acsnano.3c01829}
}
Kostenlos starten →